Evidence map›Paper›PMID 25783483›Full record

ArticleScientific reports2015

Whole-exome sequencing identifies OR2W3 mutation as a cause of autosomal dominant retinitis pigmentosa.

Xiangyu Ma, Liping Guan, Wei Wu, Yao Zhang, Wei Zheng, Yu-Tang Gao, Jirong Long, Na Wu, Long Wu, Ying Xiang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Xiangyu MaDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Liping GuanBGI-Shenzhen, Shenzhen, People's Republic of China.
Wei WuSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Yao ZhangDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Yu-Tang GaoDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai, People's Republic of China.
Jirong LongDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Na WuDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Long WuDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Ying XiangDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Bin XuDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Miaozhong ShenBGI-Shenzhen, Shenzhen, People's Republic of China.
Yanhua ChenBGI-Shenzhen, Shenzhen, People's Republic of China.
Yuewen WangBGI-Shenzhen, Shenzhen, People's Republic of China.
Ye YinBGI-Shenzhen, Shenzhen, People's Republic of China.
Yingrui Li1] BGI-Shenzhen, Shenzhen, People's Republic of China [2] BGI-Tech, Shenzhen, People's Republic of China.
Haiwei XuSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Xun XuBGI-Shenzhen, Shenzhen, People's Republic of China.
Yafei LiDepartment of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Army Medical University · CNBGI Group (China) · CNVanderbilt University · USShanghai Cancer Institute · CNSouthwest Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP), a heterogeneous group of inherited ocular diseases, is a genetic condition that causes retinal degeneration and eventual vision loss. Though some genes have been identified to be associated with RP, still a large part of the clinical cases could not be explained. Here we reported a four-generation Chinese family with RP, during which 6 from 9 members of the second generation affected the disease. To identify the genetic defect in this family, whole-exome sequencing together with validation analysis by Sanger sequencing were performed to find possible pathogenic mutations. After a pipeline of database filtering, including public databases and in-house databases, a novel missense mutation, c. 424 C > T transition (p.R142W) in OR2W3 gene, was identified as a potentially causative mutation for autosomal dominant RP. The mutation co-segregated with the disease phenotype over four generations. This mutation was validated in another independent three-generation family. RT-PCR analysis also identified that OR2W3 gene was expressed in HESC-RPE cell line. The results will not only enhance our current understanding of the genetic basis of RP, but also provide helpful clues for designing future studies to further investigate genetic factors for familial RP.

Indexed as

Asian PeopleCell LineChinaDatabases, GeneticFemaleFluorescein AngiographyGenotypeHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutation, MissensePedigreePhenotypeReceptors, OdorantRetinitis PigmentosaOR2W3 protein, humanReceptors, Odorant

Identifiers

PMID25783483
PMCPMC4363838
OpenAlexW2067944019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.